<DOC>
	<DOCNO>NCT00259285</DOCNO>
	<brief_summary>To determine response regimen therapy prior surgery patient locally advanced disease metastatic disease .</brief_summary>
	<brief_title>Pemetrexed Cisplatin Treatment Before Surgery Non Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Diagnosis nonsmallcell carcinoma lung Patients locally advance disease metastatic disease , candidate surgery evaluation oncologist thoracic surgeon Tumour possibility curative surgery At least one unidimensionally measurable lesion Adequate pulmonary function perform plan surgical resection Active infection ( investigator 's discretion ) Pregnancy breastfeed Serious concomitant illness investigator 's discretion Previous diagnosis malignant disease They receive treatment last 30 day drug , study drug , receive regulatory approval indication time entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>